Nanoveu Limited (ASX:NVU) Appoints Scott Smyser to Accelerate Semiconductor Growth
Nanoveu Limited (ASX:NVU) appoints Scott Smyser as VP Sales and Marketing to drive semiconductor growth following the EMASS acquisition.
Category: Information Technology
4DMedical Limited (ASX:4DX) Secures New Industry Contracts and Gains Congressional Recognition
4DMedical Limited (ASX:4DX) wins new industry contracts and is highlighted in US Congressional testimony on VA Healthcare modernization.
Bigtincan Holdings Limited (ASX:BTH) Approves Scheme of Arrangement
Bigtincan Holdings Limited (ASX:BTH) announces Supreme Court approval for acquisition by Vector Capital Management under a scheme of arrangement.
Excite Technology Services Limited (ASX:EXT) Reports Positive Operating Cashflows
Excite Technology Services Limited (ASX:EXT) reports positive operating cashflows and strong customer receipts in Q1 2025.
Aerometrex Limited (ASX:AMX) Awarded LiDAR Contract with Queensland Government
Aerometrex Limited (ASX:AMX) secures a $0.875 million LiDAR contract with Queensland Government, expanding its aerial mapping services.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Bigtincan Holdings Limited (ASX:BTH) Announces Proposed Acquisition and Option Scheme
Bigtincan Holdings Limited (ASX:BTH) announces a proposed acquisition by Big Wombat and outlines share and option schemes for shareholder approval.
Atomos Limited (ASX:AMS) Enters $13.7m Debt Facility
Atomos Limited (ASX:AMS) secures a $13.7m debt facility to achieve cashflow positivity by FY26, avoiding equity dilution.
PlaySide Studios (ASX:PLY) Announces Operations Restructure
PlaySide Studios (ASX:PLY) restructures operations to optimize costs while maintaining focus on major IP projects and future growth.
Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.